Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women – baseline data of a phase III vaccine trial
✍ Scribed by Lucia Six; Sepp Leodolter; Heather L. Sings; Eliav Barr; Richard Haupt; Elmar A. Joura
- Publisher
- Springer Vienna
- Year
- 2008
- Tongue
- English
- Weight
- 168 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0043-5325
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To study HPV prevalence and HPV types 6, 11, 16, 18, 31, and 33 distribution in cervical smears in a cohort of Greek women. One thousand six hundred thirty‐six samples were cytologically evaluated and molecularly analyzed, by PCR based assay. Abnormal cytology was identified in 997 wome
## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï